Prostanoid receptor with a novel pharmacological profile in human erythroleukemia cells

Biochemical Pharmacology

Volumn 54, Issue 8, 1997, Pages 917-926

  Feoktistov, Igor ^a   Breyer, Richard M ^a   Biaggioni, Italo ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fura 2; Human erythroleukemia cells; Intracellular free calcium concentration; Prostacyclin receptors; Prostaglandins; Prostanoid receptors

Indexed keywords

11 DEOXY 16 PHENOXY 17,18,19,20 TETRANORPROSTAGLANDIN E1; CALCIUM; CHOLERA TOXIN; CICAPROST; CYCLIC AMP; ILOPROST; INOSITOL PHOSPHATE; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E1; PROSTANOID RECEPTOR; THROMBIN;

ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; ERYTHROLEUKEMIA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

16,16-DIMETHYLPROSTAGLANDIN E2; ALPROSTADIL; CALCIUM; CYCLIC AMP; HUMANS; ILOPROST; INOSITOL PHOSPHATES; LEUKEMIA, ERYTHROBLASTIC, ACUTE; RECEPTORS, EPOPROSTENOL; RECEPTORS, PROSTAGLANDIN; SIGNAL TRANSDUCTION; THROMBIN; TUMOR CELLS, CULTURED;

EID: 0030766383     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00288-8     Document Type: Article

References (28)

1. Martin P and Papayannopoulou T, HEL cells: A new human erythroleukemia cell line with spontaneous and induced globin expression. Science 216: 1233-1235, 1982.
2. Papayannopoulou T, Raines E, Collins S, Nakamoto B, Tweeddale M and Ross R, Constitutive and inducible secretion of platelet derived growth factor analogs by human leukemic cell lines coexpressing erythroid and megakaryocytic markers. J Clin Invest 79: 859-866, 1987.
3. 1 via a cholera toxin-sensitive mechanism in human erythroleukemia cells. Mol Pharmacol 45: 1160-1167, 1994.
4. Wu H, James-Kracke MR and Halenda SP, Direct relationship between intracellular calcium mobilization and phospholipase D activation in prostaglandin E-stimulated human erythroleukemia cells. Biochemistry 31: 3370-3377, 1992.
5. 2+ in the human erythroleukemia cell line involve pertussis toxin-sensitive and -insensitive pathways. Biochem J 281: 301-307, 1992.
6. Murray R, Furci L and FitzGerald GA, Induction of prostacyclin receptor expression in human erythroleukemia cells. FEBS Lett 255: 172-174, 1989.
7. 1 subtype. J Biol Chem 268: 26767-26772, 1993.
8. 3 subtype from human erythroleukaemia cells. Biochem J 298: 263-267, 1994.
9. Gilman AG, A protein binding assay for adenosine 3′,5′-monophosphate. Proc Natl Acad Sci USA 67: 305-312, 1970.
10. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450, 1985.
11. 2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. J Clin Invest 96: 1979-1986, 1995.
12. Turner JT, Camden JM, Kansra S, Shelton-James D, Wu H and Halenda SP, Potentiation of cyclic adenosine monophosphate production by thrombin in the human erythroleukemia cell line HEL. J Pharmacol Exp Ther 263: 708-716, 1992.
13. Brass LF, Manning DR, Williams AG, Woolkalis MJ and Poncz M, Receptor and G protein-mediated responses to thrombin in HEL cells. J Biol Chem 266: 958-965, 1991.
14. Lazarowski ER, Winegar DA, Nolan RD, Oberdisse E and Lapetina EG, Effect of protein kinase A on inositide metabolism and rap 1 G-protein in human erythroleukemia cells. J Biol Chem 265: 13118-13123, 1990.
15. Merritt JE, Jacob R and Hallam TJ, Use of manganese to discriminate between calcium influx and mobilization from internal stores in stimulated human neutrophils. J Biol Chem 264: 1522-1527, 1989.
16. Brass LF and Woolkalis MJ, Dual regulation of cyclic AMP formation by thrombin in HEL cells, a leukaemic cell line with megakaryocytic properties. Biochem J 281: 73-80, 1992.
17. Namba T, Oida H, Sugimoto Y, Kakizuka A, Negishi M, Ichikawa A and Narumiya S, cDNA cloning of a mouse prostacyclin receptor. Multiple signaling pathways and expression in thymic medulla. J Biol Chem 269: 9986-9992, 1994.
18. s in the β-adrenergic modulation of cardiac Ca channels. Plfugers Arch 419: 433-443, 1991.
19. 2+ channel of skeletal muscle. J Biol Chem 266: 19528-19535, 1991.
20. 2-purinergic stimulation to cardiac Ca channels without cyclic AMP production. J Gen Physiol 100: 675-701, 1992.
21. Breyer RM and Breyer MD, Renal prostanoid receptors. In: Molecular Biology of the Kidney in Health and Disease (Eds. Schlondorf D and Bonventre J), pp. 201-213. Marcell Dekker, New York, 1995.
22. De Vries GW, Guarino P, McLaughlin A, Chen J, Andrews S and Woodward DF, An EP receptor with a novel pharmacological profile in the T-cell line Jurkat. Br J Pharmacol 115: 1231-1234, 1995.
23. 2 receptors. J Pharmacol Exp Ther 250: 923-927, 1989.
24. 2 receptor expression in human erythroleukemia cells. Am J Physiol 265: E928-E934, 1993.
25. 2 and its selective receptor analogue sulprostone in rabbit cortical collecting duct. Prostaglandins Leukot Essent Fatty Acids 51: 147-155, 1994.
26. Negishi M, Sugimoto Y and Ichikawa A, Molecular mechanisms of diverse actions of prostanoid receptors. Biochim Biophys Acta 1259: 109-120, 1995.
27. DeVivo M and Iyengar R, G protein pathways: Signal processing by effectors. Mol Cell Endocrinol 100: 65-70, 1994.
28. 1 subtype of prostaglandin E receptor. J Biol Chem 268: 20175-20178, 1993.